key: cord-1015234-xkp3si0d authors: Singh, Ayushi P.; Finkelstein, Mark; Bernheim, Adam; Chung, Michael title: Review of Thoracic Imaging Manifestations of COVID-19 & Other Pathologic Coronaviruses date: 2022-01-11 journal: Radiol Clin North Am DOI: 10.1016/j.rcl.2022.01.004 sha: b6b67bfc6904687d0df876a33cfc6cd9f79a7697 doc_id: 1015234 cord_uid: xkp3si0d Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an easily transmissible coronavirus that emerged in late 2019 and has caused a global pandemic characterized by acute respiratory disease named Coronavirus Disease 2019 (COVID-19). Diagnostic imaging can be helpful as a complementary tool in supporting the diagnosis of COVID-19, and identifying alternative pathology. This article presents an overview of acute and post-acute imaging findings in COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an easily transmissible coronavirus that emerged in late 2019 and has caused a global pandemic characterized by acute respiratory disease named Coronavirus Disease 2019 . Diagnostic imaging can be helpful as a complementary tool in supporting the diagnosis of COVID-19, and identifying alternative pathology. This article presents an overview of acute and post-acute imaging findings in COVID-19. Key Points: • Chest radiography (CXR) is often used as an initial diagnostic imaging tool in patients presenting with respiratory complaints. • Computed tomography (CT) is more sensitive and specific than radiography for identifying lung abnormalities in patients with COVID-19. The role of radiology in COVID-19 is evolving and may vary depending on local disease prevalence and availability of laboratory testing. Chest computed tomography (CT) findings have proven to be diagnostic in a number of cases with an initial false-negative RT-PCR screening test 13 . The positive and negative predictive value of chest CT for COVID-19 are estimated at 92% and 42%, respectively, in a population with high pretest probability for the disease (e.g. 85% prevalence by RT-PCR) 15 . The potential value of CT is that it is widely available and can be performed rapidly. However, findings on chest imaging in COVID-19 are somewhat nonspecific in many cases and may overlap with other pulmonary infections 16 . In addition, there are concerns regarding time management in the CT scanner given that scan rooms must be thoroughly cleaned after imaging a suspected COVID-19 patient, and the air needs to be recirculated 2 .Currently, the Centers for for each region if parenchymal opacification involved 0%, less than 50%, or equal or more than 50% of each region, respectively. The CT severity score was higher in patients with severe COVID-19 in comparison to patients with mild disease 19 . Chest Radiography CXR is often used as an initial diagnostic imaging tool in patients presenting with respiratory complaints. Radiography in patients with COVID-19 can vary from normal to hazy pulmonary opacities with a peripheral and lower lung distribution to frank diffuse pulmonary opacification depending on the severity of illness ( Figure 1 ). These findings may be nonspecific and can overlap with imaging findings in other diseases such as influenza, organizing pneumonia and other acute lung injuries 20 . Radiography is less sensitive than CT, with a reported baseline chest radiography sensitivity of 69% 21. CXR is an effective way to assess progress/resolution of disease over time while minimizing radiation dose ( Figure 2 ). It has been suggested that imaging in the acute phase can help predict disease severity in COVID-19. One study performed in patients aged 21-50 years with COVID-19 presenting to the emergency department demonstrated that a chest radiograph severity score was predictive of risk for hospital admission and intubation 22 found the PE incidence was higher in patients with COVID-19 than in patients with non-COVID-19 viral pneumonia who were admitted to the ICU, patients with acute respiratory distress syndrome, or patients with H1N1 influenza (swine flu) 38 . The presence of thromboembolic disease appears to be an added factor in worsened patient outcomes 39 . Deciding whether or not to image a patient for a PE can be challenging given that the symptoms of PE and COVID overlap significantly 39 Characteristics of SARS-CoV-2 and COVID-19 The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper COVID 2019) Basics. 2020. Available at: www.cdc.gov. Accessed on Overview of lethal human coronaviruses Radiology perspective of COVID-19: lessons from Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome AJR 2020 World Health Organization. Summary of probable SARS cases with onset of illness Middle east respiratory syndrome coronavirus (MERS-CoV) SARS and MERS: recent insights into emerging coronaviruses COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Coronavirus disease 2019 (COVID 19): a systematic review of imaging findings in 919 patients Sensitivity of chest CT for COVID-19: comparison to RT-PCR COVID-19): Role of Chest CT in Diagnosis and Management Coronavirus Disease 2019: Initial Detection on Chest CT in a Retrospective Multicenter Study of 103 Chinese Subjects ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. Accessed at www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendationsfor-Chest-Radiography-and-CT-for Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date Radiology Society of North America expert consensus statement on reporting Chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology and RSNA Chest CT severity score: an imaging tool for assessing severe COVID-19 Computed Tomography Features of Coronavirus Disease Frequency and distribution of chest radiographic findings in COVID-19 positive patients Clinical and chest radiography features determine patient outcomes in young and middle age adults with COVID-19 Model-based Prediction of Critical Illness in Hospitalized Patients with COVID-19 CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis COVID-19: A Multimodality Review of Radiologic Techniques, Clinical Utility, and Imaging Features Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) COVID-19-related myocarditis in a 21-year-old female patient Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region FDG PET/CT of COVID-19 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases Case 25-2020: A 47-Year-Old Woman with a Lung Mass COVID-19 Standardized Reporting Working Group of the Dutch Radiological Society. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation Acute pulmonary embolism and COVID-19 pneumonia: a random association? The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis Pulmonary Thromboembolism in COVID-19 Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia Postacute Sequelae of COVID-19 Pneumonia: 6 Month Chest CT Follow Up Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy Unilateral axillary Adenopathy in the setting of COVID-19 vaccine Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know? AJR